Fibromyalgia
Pipeline by Development Stage
Drug Modality Breakdown
On Market (8)
Approved therapies currently available
Competitive Landscape
22 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 20,506 patients across 50 trials
Micronized and Ultramicronized Palmitoylethanolamide in Fibromyalgia Patients
A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)
Inflammatory Markers and Cognitive Function in Major Depression
A Study of Duloxetine in Elderly Generalized Anxiety Disorder
A Study in Depression and Associated Painful Physical Symptoms
A Study for Adolescents With Fibromyalgia Syndrome
A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms
Duloxetine for Major Depression in Peri-/Postmenopausal Women
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
Switching to Duloxetine in Patients With Depression
A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia
A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients
Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
Duloxetine for Perimenopausal Depression
An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome
Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction
Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression
The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder
Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome
An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache
Duloxetine Treatment in Elderly With Dysthymia
Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)
Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain
A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression
A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder
A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis Pain
Zonisamide for Fibromyalgia & Migraine
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
Switching to Duloxetine From Other Antidepressants
Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression
Duloxetine vs. Active Comparator in the Treatment of Patients With Depression
Duloxetine vs. Active Comparator for the Treatment of Depression
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With Fibromyalgia
A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia
A Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia
A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder
A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480)
A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan
A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis in China
An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain
A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain
An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)
A Study of Duloxetine in Fibromyalgia